These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 26166904)

  • 1. Optimal retesting configurations for hierarchical group testing.
    Black MS; Bilder CR; Tebbs JM
    J R Stat Soc Ser C Appl Stat; 2015 Aug; 64(4):693-710. PubMed ID: 26166904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Informative Retesting.
    Bilder CR; Tebbs JM; Chen P
    J Am Stat Assoc; 2010 Sep; 105(491):942-955. PubMed ID: 21113353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pooled-testing procedures for screening high volume clinical specimens in heterogeneous populations.
    Bilder CR; Tebbs JM
    Stat Med; 2012 Nov; 31(27):3261-8. PubMed ID: 22415972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informative Dorfman screening.
    McMahan CS; Tebbs JM; Bilder CR
    Biometrics; 2012 Mar; 68(1):287-96. PubMed ID: 21762119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-stage hierarchical group testing for multiple infections with application to the infertility prevention project.
    Tebbs JM; McMahan CS; Bilder CR
    Biometrics; 2013 Dec; 69(4):1064-73. PubMed ID: 24117173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchical group testing for multiple infections.
    Hou P; Tebbs JM; Bilder CR; McMahan CS
    Biometrics; 2017 Jun; 73(2):656-665. PubMed ID: 27657666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Array testing for multiplex assays.
    Hou P; Tebbs JM; Wang D; McMahan CS; Bilder CR
    Biostatistics; 2020 Jul; 21(3):417-431. PubMed ID: 30371749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia testing and retesting patterns at family planning clinics in Australia.
    Bowring AL; Goller JL; Gouillou M; Harvey C; Bateson D; McNamee K; Read C; Boyle D; Jordan L; Wardle R; Stephens A; Donovan B; Guy R; Hellard M
    Sex Health; 2013 Mar; 10(1):74-81. PubMed ID: 23256944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missed opportunities--low levels of chlamydia retesting at Australian general practices, 2008-2009.
    Bowring AL; Gouillou M; Guy R; Kong FY; Hocking J; Pirotta M; Heal C; Brett T; Donovan B; Hellard M;
    Sex Transm Infect; 2012 Aug; 88(5):330-4. PubMed ID: 22406524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group testing in heterogeneous populations by using halving algorithms.
    Black MS; Bilder CR; Tebbs JM
    J R Stat Soc Ser C Appl Stat; 2012 Mar; 61(2):277-290. PubMed ID: 25035521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Intervention to Increase Chlamydia Retesting: A Randomized Controlled Trial in Three Populations.
    Smith KS; Hocking JS; Chen MY; Fairley CK; McNulty AM; Read P; Bradshaw CS; Tabrizi SN; Wand H; Saville M; Rawlinson W; Garland SM; Donovan B; Kaldor JM; Guy RJ
    Am J Prev Med; 2015 Jul; 49(1):1-11. PubMed ID: 26094224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group testing regression model estimation when case identification is a goal.
    Zhang B; Bilder CR; Tebbs JM
    Biom J; 2013 Mar; 55(2):173-89. PubMed ID: 23401252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal adherence to repeat testing recommendations for men and women with positive Chlamydia tests in the United States, 2008-2010.
    Hoover KW; Tao G; Nye MB; Body BA
    Clin Infect Dis; 2013 Jan; 56(1):51-7. PubMed ID: 23074316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group testing case identification with biomarker information.
    Wang D; McMahan CS; Tebbs JM; Bilder CR
    Comput Stat Data Anal; 2018 Jun; 122():156-166. PubMed ID: 29977101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retesting for repeat chlamydial infection: family planning provider knowledge, attitudes, and practices.
    Park IU; Amey A; Creegan L; Barandas A; Bauer HM
    J Womens Health (Larchmt); 2010 Jun; 19(6):1139-44. PubMed ID: 20482236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
    Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
    N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ligase chain reaction testing of pooled urine specimens to diagnose Chlamydia trachomatis infection].
    Sánchez-Alemán MA; Gutiérrez JP; Bertozzi SM; Frontela-Noda M; Guerrero-Lemus V; Conde-González CJ
    Rev Invest Clin; 2005; 57(4):548-54. PubMed ID: 16315639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating retesting outcomes for estimation of disease prevalence.
    Zhang W; Liu A; Li Q; Albert PS
    Stat Med; 2020 Mar; 39(6):687-697. PubMed ID: 31758594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for laboratory HIV testing: an examination of alternative approaches not requiring Western blot.
    Sato PA; Maskill WJ; Tamashiro H; Heymann DL
    Bull World Health Organ; 1994; 72(1):129-34. PubMed ID: 8131248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status.
    Garrison LP; Lalla D; Brammer M; Babigumira JB; Wang B; Perez EA
    Cancer; 2013 Sep; 119(17):3113-22. PubMed ID: 23775560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.